TNF and inflammatory bowel disease: In a recently published study, Cheng et al. reported that among elderly IBD patients with CCI > 1 initiating biological therapy, anti-TNF-α treatment was associated with higher rates of infection-related hospitalizations than VDZ or UST therapy [33].